Celebrating cancer research at Flinders
Flinders Foundation supports researchers at Flinders with funding to make the next discovery in cancer treatment and care.
Cancer is one of the leading causes of death worldwide. At Flinders, more than 2,500 people are diagnosed with cancer each year. In all, the Flinders Medical Centre provides in excess of 45,000 cancer-related appointments annually.
The biggest improvements and developments in cancer treatment and care have only been made possible through research. Researchers know the next breakthrough might be just around the corner. Often, the only thing stopping them is funding.
Through the generosity of individuals and organisations in the community, Flinders Foundation is currently funding more than 30 cancer research projects focused on making a difference for people affected by a range of cancer types.
Learn more about some of the projects below.
Flinders cancer research projects
Funds were raised by those who attended the 2019 Pink Yellow Blue Ball and SAPOL’s Ride Like Crazy cycling event, and generous donations from Sarah Constructions and supporters in the community. Read More
In Australia, people living with socioeconomic disadvantage, and those living rurally can face challenges with digital technologies, including accessibility, affordability, and education. Read More
New research at Flinders is focused on finding more effective treatment options for people with three aggressive forms of blood cancer. Read More
Flinders University researchers are aiming to improve the outcomes for patients with prostate cancer by introducing routine quality of life assessments and breaking down barriers to treatment. Read More
Often, by the time a person is diagnosed with brain cancer, it’s too late to cure them. It’s typically only when the cancer has progressed to a stage that it causes physical symptoms, like blurred vision, slurred speech or a lack of balance, that a person seeks medical attention. Read More
The accumulation of unrepaired and mis-repaired DNA damage can lead to cancer development. Read More
Pleural mesothelioma is a devastating cancer arising in the cells that line the lungs and chest wall. Most commonly caused by asbestos exposure, pleural mesothelioma has an extremely poor prognosis. Even with treatment, most patients die within two years of being diagnosed. Read More
A grateful patient, treated only briefly at Flinders more than three decades ago, is providing a long-lasting legacy by helping researchers to develop new treatments for men with incurable, metastatic prostate cancer. Read More
Immunotherapies have revolutionised the treatment of certain cancer types but have been largely unsuccessful in prostate cancer, despite many clinical trials. Read More
Ali Habib, recipient of the inaugural Jane Watson Ramsey PhD Scholarship in Multiple Myeloma Research, says Jane and Bill’s generosity is providing him with the opportunity to make a difference for people living with the incurable disease. Read More